To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6400 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 6400

 To amend title XVIII of the Social Security Act to extend eligibility 
for certain payment increases for biosimilar biological products under 
                         the Medicare program.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           November 14, 2023

 Mr. Cardenas introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
 To amend title XVIII of the Social Security Act to extend eligibility 
for certain payment increases for biosimilar biological products under 
                         the Medicare program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. EXTENDING ELIGIBILITY FOR CERTAIN PAYMENT INCREASES FOR 
              BIOSIMILAR BIOLOGICAL PRODUCTS UNDER THE MEDICARE 
              PROGRAM.

    Section 1847A(b)(8)(B)(ii)(II) of the Social Security Act (42 
U.S.C. 1395w-3a(b)(8)(B)(ii)(II)) is amended by striking ``2027'' and 
inserting ``2032''.
                                 <all>